Iridex (IRIX) Net Equity Issued and Repurchased (2017 - 2022)
Iridex's (IRIX) quarterly Net Equity Issued and Repurchased came in at -$9.9 million in Q4 2022, down 200.0% quarter-over-quarter from $9.9 million in Q2 2021.
Iridex (IRIX) Net Equity Issued and Repurchased (2017 - 2022) Analysis & Trends
Iridex's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at -$9.9 million for Q4 2022.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$9.9 million in Q4 2022; TTM through Sep 2025 was -$9.9 million, a 0.0% change from a year earlier, with the FY2026 full-year figure at $6.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased eased to -$9.9 million in Q4 2022 per IRIX's latest filing, from $9.9 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $9.9 million in Q2 2021 and bottomed at -$9.9 million in Q4 2022.
- The 3-year median for Net Equity Issued and Repurchased is -$162000.0 (2018), against an average of -$54000.0.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -9.88 Mn |
| Dec 31, 2022 | -9.88 Mn |
| Apr 3, 2021 | 9.88 Mn |
| Apr 3, 2021 | 9.88 Mn |
| Dec 29, 2018 | -162,000.00 |
| Dec 29, 2018 | -162,000.00 |
| Apr 1, 2017 | 2.26 Mn |
| Apr 1, 2017 | 2.26 Mn |